Stromectol is the branded oral formulation of ivermectin, typically supplied as 3 mg tablets for the treatment of parasitic infections such as nematode infestations and scabies. Pricing varies significantly depending on dosage strength, number of tablets per pack, manufacturer, and country of purchase. As a brand‑name medication, Stromectol is consistently more expensive than generic ivermectin tablets, which offer the same active ingredient at a lower cost.
Generic ivermectin tablets are widely available and provide a cost‑effective alternative for most therapeutic uses. Stromectol’s higher price reflects branding, regulatory approvals, and market positioning rather than differences in clinical efficacy. Patients comparing treatment options can benefit from understanding these price differences across regions and formulations. Explore related pricing resources: Ivermectin price, Ivermectin oral vs topical, Ivermectin vs Soolantra.
Stromectol (brand‑name ivermectin 3 mg tablets) is typically priced higher than generic ivermectin due to its branded status, regulatory positioning, and manufacturer pricing strategy. The cost varies significantly across regions, influenced by local pharmaceutical markets, availability of generics, and national pricing regulations. In contrast, generic ivermectin 3 mg remains widely accessible and considerably more affordable.
As a branded antiparasitic medication, Stromectol commands a premium price. Factors contributing to its higher cost include:
Stromectol is often several times more expensive than generic equivalents.
Generic ivermectin tablets offer the same active ingredient at a substantially lower price. Their affordability is driven by:
Stromectol pricing varies widely across regions. High‑income countries typically have higher retail prices due to regulatory frameworks and branded market dominance. In contrast, low‑ and middle‑income countries often rely on generics, resulting in significantly lower costs.
| Form | Dosage | Price range | Comment |
|---|---|---|---|
| Stromectol tablets | 3 mg | High | Brand‑name; premium pricing |
| Generic ivermectin tablets | 3 mg | Low | Most affordable option; widely available |
| Regional variations | 3 mg | Wide variation | Prices differ significantly by country |
Stromectol 3 mg is the standard branded oral formulation of ivermectin. As a Merck‑manufactured product, it carries a premium price compared with generic ivermectin tablets. The cost varies depending on the number of tablets per pack, regional pricing policies, and pharmacy distribution channels. In most markets, Stromectol is positioned as a higher‑tier antiparasitic medication, while generics serve as the budget alternative.
Stromectol is available exclusively in the 3 mg strength. This dosage is used globally for parasitic infections, including strongyloidiasis and onchocerciasis. Because the strength is fixed, price differences arise primarily from pack size and brand‑related markups rather than dosage variation.
Stromectol is commonly sold in packs of:
The price increases proportionally with the number of tablets, but the cost per tablet may decrease slightly in larger packs depending on the region.
As a branded medication, Stromectol includes:
This results in a significantly higher price compared with generic ivermectin 3 mg tablets, which are produced by dozens of manufacturers worldwide.
| Pack size | Dosage | Price range | Comment |
|---|---|---|---|
| 2 tablets | 3 mg | High | Small pack; highest cost per tablet |
| 4 tablets | 3 mg | High | Brand premium remains significant |
| 6 tablets | 3 mg | High | Cost per tablet slightly lower |
| 10 tablets | 3 mg | High | More economical per tablet |
| 20 tablets | 3 mg | High | Best value per tablet; still premium‑priced |
The price difference between Stromectol (Merck’s branded ivermectin) and generic ivermectin tablets is substantial. Although both contain the same active ingredient—ivermectin 3 mg—their market positioning, manufacturing costs, and regulatory pathways differ significantly. The logic is similar to the branded vs generic comparison seen in Ivermectin vs Soolantra.
Stromectol is produced by Merck and benefits from:
These factors contribute to its significantly higher price, even though the active ingredient is identical to generics.
Generic ivermectin tablets are produced by dozens of pharmaceutical companies worldwide. Their affordability is driven by:
Generics offer the same therapeutic effect at a fraction of the cost.
Both Stromectol and generic ivermectin contain ivermectin 3 mg with identical pharmacological action. Differences lie in excipients, packaging, and branding—not in efficacy.
In many markets, Stromectol can cost 5–10× more than generic ivermectin. This makes generics the preferred option for cost‑sensitive patients and large‑scale public health programs.
| Product | Dosage | Price range | Comment |
|---|---|---|---|
| Stromectol (Merck) | 3 mg | High | Brand premium; regulated pricing |
| Generic ivermectin | 3 mg | Low | Multiple manufacturers; lowest cost |
| Price difference | 3 mg | Wide variation | Stromectol often 5–10× more expensive |
The cost of Stromectol varies across markets depending on dosage strength, availability, and regional regulatory policies. Although the branded formulation is most commonly sold as 3 mg tablets, some countries also offer 6 mg and, more rarely, 12 mg strengths. These variations influence pricing, but the overall trend remains consistent: Stromectol is significantly more expensive than generic ivermectin due to its branded status and manufacturer premium. More details on tablet strengths are available at Ivermectin 3 mg tablets and Ivermectin 6 mg tablets.
The 3 mg strength is the standard and most widely distributed form of Stromectol. It is used globally for parasitic infections and serves as the reference dosage for most treatment protocols. Because it is the flagship branded product, it carries the highest relative price premium compared with generics.
In some regions, Stromectol is also available in 6 mg tablets. These are typically priced higher per tablet but may offer better value per milligram. Availability is limited, and in many countries only generics exist in this strength.
The 12 mg strength is uncommon and usually supplied only in markets with broader ivermectin demand or where higher‑dose tablets simplify treatment logistics. Pricing is generally the highest per unit but may be more economical per milligram.
| Strength | Form | Price range | Comment |
|---|---|---|---|
| 3 mg | Tablet | High | Main branded strength; highest premium |
| 6 mg | Tablet | High | Available only in select countries |
| 12 mg | Tablet | High | Rare; price varies widely by region |
The cost of Stromectol (ivermectin 3 mg) varies depending on the clinical scenario, regional pricing policies, and whether branded Stromectol or generic ivermectin is used. Although Stromectol is a branded medication with a premium price, its use across different parasitic and dermatologic conditions follows similar economic patterns. The information below is non‑directive and reflects general pricing tendencies across markets. Additional comparisons are available at Ivermectin vs Permethrin and Ivermectin for demodex.
For systemic parasitic infections such as strongyloidiasis and onchocerciasis, Stromectol is often used in multi‑tablet regimens. Because these conditions may require repeated dosing, the cost can increase proportionally with the number of tablets. In many regions, generic ivermectin is preferred due to significantly lower pricing, especially for large‑scale public health programs.
In scabies management, Stromectol may be used as part of systemic therapy. Treatment often requires multiple tablets per dose and repeated dosing after 7–14 days. This increases total cost when using branded Stromectol. Generic ivermectin is widely used as a more economical alternative, while topical permethrin remains the lowest‑cost option in many countries.
Oral ivermectin for Demodex infestation is considered off‑label in many regions. Stromectol is sometimes used when topical therapy is insufficient. Because Demodex‑associated dermatoses may require repeated or combination therapy, branded Stromectol can become costly. Generic ivermectin tablets significantly reduce expenses and are commonly used in off‑label dermatologic protocols.
| Clinical scenario | Preferred form | Price range | Comment |
|---|---|---|---|
| Strongyloides / Onchocerca | Oral 3 mg tablets | High | Multiple tablets needed; branded premium |
| Scabies | Oral 3 mg tablets | High | Repeated dosing increases total cost |
| Demodex (off‑label) | Oral 3 mg tablets | High | Off‑label; generics often preferred for cost |
The price of Stromectol (brand‑name ivermectin 3 mg) is shaped by a combination of pharmaceutical, regulatory, and commercial variables. As a branded Merck product, Stromectol consistently occupies the premium segment of the antiparasitic market. Its cost often exceeds that of generic ivermectin by a wide margin, and the degree of price variation depends heavily on regional market conditions and distribution policies.
Stromectol’s pricing reflects its originator status. The Merck brand carries:
This branding effect is one of the strongest contributors to Stromectol’s elevated price.
Prices vary significantly depending on where Stromectol is produced and sold. High‑income countries typically have higher retail prices due to strict regulatory frameworks, while markets with strong generic competition may show wider price gaps between Stromectol and generic ivermectin.
Stromectol is sold in packs of 2, 4, 6, 10, or 20 tablets. While the total price increases with pack size, the cost per tablet may decrease in larger packs. Smaller packs often carry the highest per‑tablet premium.
Although Stromectol is primarily available as 3 mg tablets, some markets offer 6 mg or 12 mg strengths. Higher strengths typically cost more per unit but may offer better value per milligram.
Pharmacy chains, wholesalers, and online distributors apply their own commercial markups. These policies can significantly affect final retail pricing, especially in regions with limited competition.
| Cost factor | Impact |
|---|---|
| Merck branding | Major premium due to originator status |
| Country of manufacture | Regulation and market competition affect price |
| Pack size | Larger packs reduce cost per tablet |
| Dosage strength | Higher strengths cost more per unit |
| Distributor policy | Markup varies by pharmacy and region |
Stromectol (Merck’s branded ivermectin 3 mg) occupies the premium end of the antiparasitic market. Its cost is consistently higher than that of generic ivermectin tablets and significantly higher than older topical antiparasitic agents such as benzyl benzoate or permethrin. The comparison below focuses on pricing logic, formulation differences, and market positioning. Additional related analyses are available at Ivermectin price, Soolantra price, Ivermectin vs Benzyl benzoate, Ivermectin vs Permethrin.
The most direct comparison is between Stromectol and generic ivermectin tablets. Both contain the same active ingredient (ivermectin 3 mg), but Stromectol is priced substantially higher due to Merck branding, regulatory positioning, and distribution costs. Generics, produced by dozens of manufacturers, offer the lowest cost per tablet and are widely used in both clinical and public‑health settings.
Although Soolantra is a topical ivermectin cream rather than an oral formulation, the pricing logic is similar: branded dermatology products carry a premium. Soolantra is typically more expensive than Stromectol on a per‑treatment basis due to its cosmetic vehicle and dermatology‑grade formulation. Stromectol remains cheaper overall but serves different indications.
Benzyl benzoate is one of the cheapest antiparasitic topicals available. Its extremely low price reflects its age, simple formulation, and lack of cosmetic refinement. However, it is highly irritating and unsuitable for facial use. Stromectol is far more expensive but significantly safer and better tolerated.
Permethrin (5% cream) is inexpensive and widely used for scabies. It is typically cheaper than Stromectol, especially in generic form. However, permethrin is topical only, while Stromectol provides systemic therapy when topical treatment is insufficient or contraindicated.
| Treatment | Typical price | Comment |
|---|---|---|
| Stromectol (Merck) | High | Branded systemic antiparasitic; premium pricing |
| Generic ivermectin tablets | Low | Same active ingredient; lowest cost option |
| Soolantra (topical) | Very high | Dermatology‑grade vehicle; different indication |
| Benzyl benzoate | Very low | Cheap but highly irritating |
| Permethrin | Low | Inexpensive topical alternative for scabies |
The economic efficiency of Stromectol (Merck’s branded ivermectin 3 mg) depends on how its cost aligns with treatment duration, dosing requirements, and the value attributed to its branded formulation. Although Stromectol is consistently more expensive than generic ivermectin, its economic profile varies across clinical scenarios and markets. The following overview is informational and reflects general pricing logic rather than therapeutic recommendations.
Stromectol provides a systemic antiparasitic effect that often requires only one or two doses depending on the indication. This short treatment duration can partially offset its higher per‑tablet price. In conditions where a single therapeutic course is sufficient, the economic gap between Stromectol and generics becomes less pronounced, though still significant.
Because Stromectol is primarily available as 3 mg tablets, total treatment cost scales with the number of tablets required. Multi‑tablet regimens (e.g., scabies, strongyloidiasis) increase overall expense, especially when repeated dosing is needed. In such cases, generic ivermectin offers a substantially more economical alternative, particularly for large‑scale or repeated treatments.
Stromectol’s premium price reflects Merck’s manufacturing standards, regulatory approvals, and distribution network. While the active ingredient is identical to generics, the branded formulation carries a higher perceived value in some markets. However, from a purely economic standpoint, generics deliver the same pharmacological effect at a fraction of the cost, making Stromectol less cost‑efficient in price‑sensitive settings.
| Economic factor | Impact |
|---|---|
| Duration of effect | Short treatment courses partially offset high price |
| Dosage requirements | More tablets → higher total cost |
| Branded formulation | Premium pricing due to Merck branding |
| Overall value | Lower cost‑efficiency vs generics |